-
REAL-WORLD COMPARISON OF OLANZAPINE/SAMIDORPHAN VS OLANZAPINE: AN ASSESSMENT OF TREATMENT PATTERNS AND ACUTE CARE EVENTS AMONG PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR I DISORDER
Feb 25, 2026, 14:42 PM -
AN INDIRECT TREATMENT COMPARISON (ITC) OF IFINATAMAB DERUXTECAN (I-DXD) VERSUS REAL-WORLD PHYSICIAN’S CHOICE OF THERAPY (RWPCT) IN PATIENTS PREVIOUSLY TREATED WITH AT LEAST 2 LINES OF THERAPY (LOTS) FOR EXTENSIVE-STAGE SMALL CELL LUNG CANCER...
Feb 25, 2026, 14:42 PM -
A MULTI-AGENT GENAI SYSTEM FOR TRACEABLE, MULTI-COUNTRY LANDSCAPE ASSESSMENT IN MASH
Feb 25, 2026, 14:42 PM -
COST-EFFECTIVENESS OF A NOVEL THERAPY TO PREVENT ADVANCED FRAILTY AMONG PEOPLE WITH HIV
Feb 25, 2026, 14:42 PM -
ENDOCRINE RESISTANCE AND REAL-WORLD TREATMENT PATTERNS AFTER FIRST-LINE (1L) ET+CDK4/6I IN HR+/HER2-METASTATIC BREAST CANCER (MBC)
Feb 25, 2026, 14:42 PM -
ESTIMATING THE COST-EFFECTIVENESS OF SPARSENTAN RELATIVE TO REAL-WORLD RENIN-ANGIOTENSIN SYSTEMINHIBITION STANDARD OF CARE FOR IMMUNOGLOBULIN A NEPHROPATHY: A PATIENT-LEVEL MICROSIMULATION
Feb 25, 2026, 14:42 PM -
VALIDATION OF THE REAL-Q (REAL-WORLD EVALUATION ASSESSMENT LIST FOR QUALITY) TOOL
Feb 25, 2026, 14:42 PM -
EMERGENCY GENERAL SURGERY OUTCOMES AT CRITICAL ACCESS HOSPITALS COMPARED WITH RURAL NON-CRITICAL ACCESS AND URBAN HOSPITALS IN KENTUCKY (2016-2024)
Feb 25, 2026, 14:42 PM -
OPTIMIZATION OF PROSTATE CANCER BIOPSY DECISION-MAKING IN KOREAN PATIENTS USING MACHINE LEARNING
Feb 25, 2026, 14:42 PM -
GLOBAL BURDEN OF MULTIPLE SCLEROSIS AND FUTURE PROJECTIONS: EVIDENCE FROM GBD 2023
Feb 25, 2026, 14:42 PM -
REAL-WORLD HEALTHCARE UTILIZATION AND CLINICAL CHARACTERISTICS ACROSS DIABETES COMPLICATIONS SEVERITY IN MEDICARE ADVANTAGE INSURED ADULTS WITH TYPE 2 DIABETES
Feb 25, 2026, 14:42 PM -
DR. TAORAN LIU
Feb 25, 2026, 14:42 PM -
FUELING FRICTIONS: HOW NIGERIA’S FUEL SUBSIDY REMOVAL RESHAPED HEALTH ACCESS
Feb 25, 2026, 14:42 PM -
REAL-WORLD INSIGHTS INTO OBESITY PATHWAYS, PRESCRIBING, PATIENT COMPLEXITY, AND CARE GAPS THROUGH PRIMARY CARE DATABASES
Feb 25, 2026, 14:42 PM -
WHO IS MOST AT RISK OF UNRECOGNIZED DIABETES? A STUDY TO INFORM PHARMACIST ACTION
Feb 25, 2026, 14:42 PM -
ASSESSING DISTRIBUTION OF SOCIAL AND PRIVATE VALUE CREATION BY DRUGS REGULATING PROGRAMMED CELL DEATH-1IN CANCER TREATMENT...
Feb 25, 2026, 14:42 PM -
PERSONALITY PROFILES AND BURNOUT DIMENSIONS AMONG EMERGENCY CARE PROFESSIONALS IN HUNGARY: A CROSS-SECTIONAL STUDY
Feb 25, 2026, 14:42 PM -
REAL-WORLD TREATMENT PATTERNS AND EFFICACY OF FIRST-LINE THERAPIES IN PATIENTS WITH MET EXON 14 SKIPPING-MUTATED NON-SMALL CELL LUNG CANCER
Feb 25, 2026, 14:42 PM -
INDIRECT ECONOMIC BURDEN OF ADULT OVERWEIGHT AND OBESITY: A SYSTEMATIC REVIEW TO INFORM POLICY AND ECONOMIC MODELING IN COLOMBIA
Feb 25, 2026, 14:42 PM -
INVESTIGATING THE CHARACTERISTICS ASSOCIATED WITH MULTIMORBIDITY (=2 CO-OCCURRING CONDITIONS IN AN INDIVIDUAL) AMONG UNITED STATES ADULTS WITH A DIAGNOSIS OF ASTHMA
Feb 25, 2026, 14:42 PM
